Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Versant Ventures
Biotech
Versant unveils new autoimmune biotech with $100M fundraise
Granite has raised combined series A and B funds of $100 million, with support from Versant Ventures, Novartis, Forbion and Sanofi.
Gabrielle Masson
Apr 24, 2025 8:00am
Versant launches another obesity biotech with $65M series A
Jan 28, 2025 8:35am
Right out of the gate, Light Horse nabs $62M and Novartis deal
Jan 9, 2025 4:26pm
Antag secures $84M series A for GLP-1 add-on
Dec 4, 2024 3:00am
Versant unveils Pep2Tango, a biotech with next-gen obesity hopes
Nov 21, 2024 11:11am
Novartis, Versant hope to repeat Chinook’s success with Borealis
Aug 22, 2024 8:00am
